Dr. Apovian is Co-Director of the Center for Weight Management and Wellness (CWMW) in the Division of Endocrinology, Diabetes, and Hypertension at Brigham and Women’s Hospital and a member of the faculty at Harvard Medical School. For over thirty years, Dr. Apovian has held a position at the forefront of the obesity and nutrition fields. One of the world’s premier weight management experts, she has distinguished herself as a leading researcher, healthcare provider, teacher, and New York Times bestselling author.
In collaboration with the Division of Gastroenterology, Hepatology and Endoscopy and the Division of Gastrointestinal and General Surgery, the CWMW will offer comprehensive, multidisciplinary care for patients seeking weight loss. Under Dr. Apovian’s direction, the Endocrinology arm of the Center will specialize in the assessment and treatment of obesity and its comorbidities. Nationally, she is one of the founding creators of the American Board of Obesity Medicine which provides certification and recognition for physicians who have specialized knowledge and training in the practice of obesity medicine.
Her current research interests are weight change and its effects on adipose tissue metabolism and inflammation, obesity and cardiovascular disease, resolution of type 2 diabetes and cardiovascular disease in the bariatric surgery population, disparities in the treatment of obesity in underserved populations, and novel pharmacotherapeutic agents for the treatment of obesity. She is also an expert in sampling subcutaneous adipose tissue and muscle tissue in humans and has been studying the relationship between adipose tissue inflammation and obesity for over 15 years.
Apovian博士出版了十多本书,并进行了200多本同行评审的原始研究和评论有关肥胖和营养的文章。Apovian博士是更新2013 AHA/ACC/TOS的专家小组成员成人超重和肥胖管理的临床指南,发表在Circulation和Obesity期刊,是内分泌学会的肥胖医学治疗指南,发表在Journal of Endocrinology and Metabolismin 2015. She is a former Nutrition Consultant for the National Aeronautics and Space Administration (NASA). Dr. Apovian has given over 200 invited lectures nationally and internationally and served as President of The Obesity Society in 2017-2018. She is also currently the Co-Director for the NIH-funded Boston Nutrition and Obesity Research Center.
Apovian博士参加了Abbott Nutrition,Allergan,Inc。,Altimmmune,Inc。,Cowen and Company,LLC的咨询委员会,Curavit临床研究,EnteroMedics,GeLesis,Srl。,Jazz Pharmaceuticals,Inc。,L-Nutra,Inc。,Neurobo Pharmaceuticals,Inc。,Novo Nordisk,Inc。,Pain Script Corporation,Pain Script Corporation,Real Vlice Flice,Riverview School,Rhythm Pharmaceuticals,Roman Health Ventures,Inc。,Scientific Intake Ltd. Co.,Tivity Health,Inc。,Xeno Biosciences和Zafgen Inc.Apovian博士已获得NIH,PCORI,GI Dynamics Inc.和Novo Nordisk的研究资金。
Aronne博士是肥胖及其治疗的领先权威。他是Weill-Cornell医学院代谢研究教授Sanford I. Weill教授,并指导体重管理和代谢临床研究中心,这是一项最先进的多学科肥胖研究和治疗计划。他在哥伦比亚大学医师和外科医生学院任命。Aronne博士是创始人兼首席执行官BMIQ,在办公室访问期间,医疗保健提供者向患者提供了一项体重控制计划。Aronne博士毕业于三一学院的Phi Beta Kappa,并获得了生物化学学士学位和约翰·霍普金斯大学医学院的学士学位。他在艾伯特·爱因斯坦医学院和布朗克斯市医院中心完成了实习和居留权,随后是纽约医院医学中心的亨利·J·凯撒家庭基金会奖学金。他是Alpha Omega Alpha医学荣誉学会的成员。Aronne博士是肥胖学会的前校长,也是美国医师学院的会员。美国肥胖医学委员会董事会副主席,他撰写了60多篇有关肥胖症的论文和书籍章节,并编辑了美国国立卫生研究院Practical Guide to the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults。他曾担任VA体重管理/体育活动执行委员会的顾问移动计划是美国最大的基于医学的体重控制计划。Aronne博士赢得了几项医学教学奖,包括来自Albert Einstein医学院的Davidoff奖和康奈尔大学的Elliot Hochstein奖。
Dr. Aronne reports receiving consulting fees from/and serving on advisory boards for Allurion, Altimmune, Atria, Gelesis, Jamieson Wellness, Janssen Pharmaceuticals, Jazz Pharmaceuticals, Novo Nordisk, Pfizer, Optum, Eli Lilly, Senda Biosciences and Versanis; receiving research funding from Allurion, Astra Zeneca, Gelesis, Janssen Pharmaceuticals, Novo Nordisk and Eli Lilly; having equity interests in Allurion, ERX Pharmaceuticals, Gelesis, Intellihealth, Jamieson Wellness and Myos Corp; and serving on a board of directors for ERX Pharmaceuticals, Intellihealth and Jamieson Wellness.
董事会成员:ERX Pharmaceuticals,Intellihealth Corp,Jamieson Wellness。股权利益:Allurion,Erx Pharmaceuticals,Gelesis,Intellihealth,Jamieson Wellness,Myos Corp.研究资金:Allurion,Allurion,Astrazeneca,Gelesis,Gelesis,Janssen Pharmaceuticals,Novo Nordisk,Novo Nordisk,Eli Lilly。顾问/顾问委员会成员:Allurion,Altimmune,Atria,Gelesis,Jamieson Wellness,Janssen Pharmaceuticals,Jazz Pharmaceuticals,Novo Nordisk,Pfizer,Optum,Optum,Eli Lilly,Eli Lilly,Senda Biosciences,Versanis,Versanis,Versanis
Dr. Barenbaum is an Assistant Professor of Clinical Medicine at Weill Cornell Medical College and an Assistant Attending Physician at NewYork-Presbyterian Hospital. Dr. Barenbaum specializes in the care of patients with obesity and weight-related medical complications.Dr. Barenbaum sees patients at the Comprehensive Weight Control Center, and also with the GI Metabolic and Bariatric Surgery program, where she serves as the Obesity Medicine Director.
Dr. Barenbaum received her B.A. from Yale University, where she won two NCAA Division I national championships in squash and received the College Squash Assocation's scholar athlete award. She received her M.D. from Drexel University College of Medicine, where she won the Samuel M. Levit Award for Clinical Excellence & Bridging the Gaps Clinical Scholar. Dr. Barenbaum completed both her Residency & Obesity Medicine Fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital.
No financial relationships to disclose
资源:Content for this module was reproduced with permission from: Apovian CM, Aronne L, Barenbaum SR.Clinical Management of Obesity。2nded。专业通信公司2022.保留所有权利。
Get the latest news and education delivered to your inbox
© 2022 Healio All Rights Reserved.